Form 4: OptiNose Director Sandra L. Helton Acquires 75,000 Stock Options

Director Sandra L. Helton acquired 75,000 stock options in OptiNose, Inc. on June 6, 2024.

Summary

• Sandra L. Helton, a director of OptiNose, Inc., reported a transaction involving derivative securities.
• On June 6, 2024, Helton acquired 75,000 stock options with an exercise price of $1.04.
• The options vest and become exercisable on the earlier of June 6, 2025, or the Issuer's 2025 annual meeting of stockholders, contingent upon continued service with the Issuer.
• The expiration date for these options is June 6, 2034.
• Following the reported transaction, Helton directly owns 75,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's acquisition of stock options. While it can be seen as a positive sign of confidence, it's not inherently indicative of significant positive or negative sentiment.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.

Key Dates